Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Total ginsenosides enhance γ-globin expression and fetal hemoglobin production in β-thalassemia models. | Front Pharmacol | 2025 | 40918511 | PubTator, text mining | PubMed |
| A streamlined base editor engineering strategy to reduce bystander editing. | Nat Commun | 2025 | 40885742 | PubTator, text mining | PubMed |
| A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease. | Blood | 2025 | 40857666 | PubTator, text mining | PubMed |
| Metagenomic analysis and genomic characterization of enterovirus A76 and Norovirus GI.6[P11] co-infection in a patient with acute gastroenteritis in Thailand. | Sci Rep | 2025 | 40835708 | PubTator, text mining | PubMed |
| Stabilization of norovirus GII.3 virus-like particles by rational disulfide engineering. | NPJ Vaccines | 2025 | 40830611 | PubTator, text mining | PubMed |
| Mechanisms of Globin Gene Regulation in Mammals. | Annu Rev Genet | 2025 | 40829781 | PubTator, text mining | PubMed |
| Sirolimus modulates the erythroid differentiation of K562 cells by upregulating SHP1. | Ann Hematol | 2025 | 40825899 | PubTator, text mining | PubMed |
| BMI1 regulates human erythroid self-renewal through both gene repression and gene activation. | Nat Commun | 2025 | 40817093 | PubTator, text mining | PubMed |
| Removal of promoter CpG methylation by epigenome editing reverses HBG silencing. | Nat Commun | 2025 | 40715076 | PubTator, text mining | PubMed |
| Disrupting ZBTB7A or BCL11A binding sites reactivates fetal hemoglobin in erythroblasts from healthy and β0-thalassemia/HbE individuals. | Sci Rep | 2025 | 40665149 | PubTator, text mining | PubMed |
| Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies. | Nucleic Acids Res | 2025 | 40637230 | PubTator, text mining | PubMed |
| KLF1 Knockdown Differentially Regulates γ-Globin Expression: Inhibition in K562 Cells but Reactivation in β-Thalassemia Major Erythrocytes with Erythropoiesis Disruption. | Hemoglobin | 2025 | 40619594 | PubTator, text mining | PubMed |
| Fetal-hemoglobin-expressing red blood cells ("F cells") consist of three distinct types as revealed by single-cell transcriptomic analysis of circulating reticulocytes. | Hemasphere | 2025 | 40568351 | PubTator, text mining | PubMed |
| Orphan Nuclear Receptors TR2 and TR4 in Erythropoiesis: From Mechanisms to Therapies. | Biomolecules | 2025 | 40563438 | PubTator, text mining | PubMed |
| Human milk oligosaccharide secretion dynamics during breastfeeding and its antimicrobial role: A systematic review. | World J Clin Pediatr | 2025 | 40491725 | PubTator, text mining | PubMed |
| Hereditary Persistence of Fetal Hemoglobin (HPFH): Detection of Unknow Aγ-Globin Promoter Mutation at the C2H2 Zinc Finger Transcription Factors Binding Sites. | Hemoglobin | 2025 | 40485163 | PubTator, text mining | PubMed |
| Assessing the safety of gene therapy vectors expressing an enhanced gamma-globin gene for the cure of sickle cell anemia. | Mol Ther Methods Clin Dev | 2025 | 40469750 | PubTator, text mining | PubMed |
| Tapping into Metabolomics for Understanding Host and Rotavirus Group A Interactome. | Life (Basel) | 2025 | 40430193 | PubTator, text mining | PubMed |
| Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy. | Nat Commun | 2025 | 40425554 | PubTator, text mining | PubMed |
| Investigate the Effect of ZFP64 on mRNA Expression of HBG Based on Bioinformatics and Experimental Validation. | Cell Biochem Biophys | 2025 | 40392482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=5